Safecor Health Recalls Metoclopramide Tablets Due to Co-Mingled Tablets
Safecor Health, LLC is recalling specific lots of Metoclopramide Tablets due to co-mingled tablets. The recall covers products distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as Class II due to co-mingled tablets. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Safecor Health, LLC is recalling Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle. The recall is due to co-mingled tablets. The affected product is identified by Lot # 3116509 with an expiry date of 07/31/2027. The product is manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, and carries the NDC 51079-886-20.
The recall is classified as Class II by the U.S. Food and Drug Administration. The source text does not report any illnesses, injuries, or deaths associated with this recall. The distribution pattern is listed as US Nationwide.
Consumers should check their medication for the specific lot number and expiry date listed above. If the product matches the recalled lot, consumers should stop using it and contact their healthcare provider or pharmacist for guidance on replacement or disposal.
The recalled product
- Product
- METOCLOPRAMIDE (METOCLOPRAMIDE)
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Safecor Health, LLC
- Category
- Drug — Prescription Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 3116509
- Expiry: 07/31/2027.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOCLOPRAMIDE
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- SevereMetoclopramide Tablets Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2025-07-02
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-05-26
Same manufacturer · Safecor Health, LLC
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Same hazard · contamination
See all →- ModeratePentax Medical Water Bottle Assembly Recalled for Sterile Water Warnings
FDA (Devices) · 2026-11-04
- SevereAVID Medical Recalls Halyard Anterior Hip Packs Due to Sterilization Error
FDA (Devices) · 2026-10-28
- SevereFDA Recalls Argatroban Injection Vials Due to Particulate Matter
FDA (Drugs) · 2026-10-28
- SevereGreiner VACUETTE Blood Collection Tubes Recalled for EDTA Contamination
FDA (Devices) · 2026-10-28
- ModerateBioFire FilmArray Pneumonia Panel Recalled for Potential Contamination
FDA (Devices) · 2026-10-21
Similar recalls
- SevereMetoclopramide Tablets Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2025-07-02
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-05-26
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
- ModerateTeva Recalls Methylphenidate Hydrochloride Extended-Release Tablets Due to Missing Desiccant
FDA (Drugs) · 2020-02-19